Single Source Procurement: Sickle Cell Reagent Test Kits
Pursuant to New York State Finance Law § 163.10(b), The New York State Department of Health is presenting the following summary of relevant circumstances, and material and substantial reasons why a competitive procurement was not feasible. Bio-Rad’s VARIANT™nbs Sickle Cell program is currently the ONLY FDA approved under Sec. 864.7415, Abnormal hemoglobin assay, inclusive of an HPLC system device, software and testing reagents. (FDA 510(k) # K080911).
Procurement / Program Name | Sickle Cell Reagent Test Kits |
---|---|
Contractor Name(s) | Bio-Rad Laboratories, Inc. |
Contract Period | 10/1/18- 9/3/23 |
Contract Number | PA32230 |